These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6114884)

  • 1. Double-blind crossover study of carbuterol and salbutamol in bronchial asthma.
    Misra NP; Tiwari UC; Khemchandani GT
    J Int Med Res; 1981; 9(4):261-7. PubMed ID: 6114884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of carbuterol and salbutamol from metered aerosols in bronchial asthma.
    Beumer HM; Mills JG; Sharpe PC
    Respiration; 1978; 35(4):220-3. PubMed ID: 345380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, crossover comparison of carbuterol and salbutamol.
    Guleria JS; Vasu KV; Pande JN
    Ann Allergy; 1979 Aug; 43(2):123-5. PubMed ID: 380412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children.
    Rhoades RB; Leifer KN; Bloom FL; Wittig HJ
    Am Rev Respir Dis; 1976 Jul; 114(1):79-86. PubMed ID: 7174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of bronchodilator effects of carbuterol and ephedrine.
    James TD; Lyons HA
    JAMA; 1979 Feb; 241(7):704-5. PubMed ID: 368368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind trial of oral carbuterol in bronchial asthma.
    Miller J; Wallace D; Grieco MH; Frenkel R; Larsen K
    Ann Allergy; 1977 Jul; 39(1):12-7. PubMed ID: 18957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of carbuterol and hexoprenaline aerosol in bronchial asthma.
    Irsigler GB; Ker J
    S Afr Med J; 1978 Apr; 53(15):571-3. PubMed ID: 354041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spirometric comparison of carbuterol and salbutamol oral therapy in reversible obstructive airway disease.
    Kulpati DD; Bogra KC; Kinra V; Datta TK
    Indian J Chest Dis Allied Sci; 1980; 22(3):158-65. PubMed ID: 7011953
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbuterol, fenoterol, orciprenaline, salbutamol and terbutaline per os in reversible obstructive chronic bronchitis.
    Minette A; Marcq M; Gepts L
    Bull Eur Physiopathol Respir; 1976; 12(4):545-53. PubMed ID: 13895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    Dyson AJ; Mackay AD
    Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study with cumulative doses of formoterol and salbutamol in children with asthma.
    Foucard T; Lönnerholm G
    Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between oral procaterol and salbutamol in patients with bronchial asthma.
    Tukiainen H; Jaakkola J; Torkko M; Terho EO
    Curr Med Res Opin; 1988; 11(4):236-41. PubMed ID: 2975204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind cross-over comparison of clenbuterol and salbutamol tablets in asthmatic out-patients.
    Salorinne Y; Stenius B; Tukiainen P; Poppius H
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):189-95. PubMed ID: 9295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
    Morin D; Milot J; Turcotte H; Boulet LP
    Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic and cardiovascular effects of carbuterol and metaproterenol.
    Sanders JP; Potter DE; Ellis S; Bee DE; Grant JA
    J Allergy Clin Immunol; 1977 Sep; 60(3):174-9. PubMed ID: 19514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S; Hancox RJ
    Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
    Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
    Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.